Benjamin Levi

Benjamin Levi

Auto-generated profile, based on publicly available information

Benjamin Levi

Department of Surgery, University of Michigan, Ann Arbor, MI 48109, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2015 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
KRKavitha Ranganathan
Kavitha Ranganathan
SLShawn Loder
Shawn Loder
SAShailesh Agarwal
Shailesh Agarwal
VWVictor W. Wong
Victor W. Wong
JFJonathan Forsberg
Jonathan Forsberg
BLBenjamin Levi
Benjamin Levi
This article was updated on July 22, 2015, because the name of one of the authors, Victor W. Wong, was listed incorrectly. The name, which previously read “Victor C. Wong,” on pages 1101 and 1108, now reads “Victor W. Wong.” An erratum has been published: J Bone Joint Surg Am. 2015 Sep 2;97(17):e59. ➤ Heterotopic ossification occurs most commonly after joint arthroplasty, spinal cord injury, traumatic brain injury, blast trauma, elbow and acetabular fractures, and thermal injury. ➤ The conversion of progenitor cells to osteogenic precursor cells as a result of cell-mediated interactions with the local tissue environment is affected by oxygen tension, pH, availability of micronutrients, and mechanical stimuli, and leads to heterotopic ossification. ➤ Radiation and certain nonsteroidal anti-inflammatory medications are important methods of prophylaxis against heterotopic ossification. ➤ Well-planned surgical excision can improve patient outcomes regardless of the joint involved or the initial cause of injury. ➤ Future therapeutic strategies are focused on targeted inhibition of local factors and signaling pathways that catalyze ectopic bone formation.

31 December 2015 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SAShailesh Agarwal
Shailesh Agarwal
SLShawn Loder
Shawn Loder
CBCameron Brownley
Cameron Brownley
DCDavid Cholok
David Cholok
LMLaura Mangiavini
Laura Mangiavini
BLBenjamin Levi
Benjamin Levi
Significance: Heterotopic ossification (HO) is a debilitating condition in which bone forms inappropriately within soft tissues. Two vastly different patient populations are at risk for developing HO: those with musculoskeletal trauma or severe burns and those with a genetic mutation in the bone morphogenetic protein receptor ACVR1 (Activin type 1 receptor). In this study, we demonstrate that both forms of HO share a common signaling pathway through hypoxia inducible factor-1α, and that pharmacologic inhibition or genetic knockout of this signaling pathway can mitigate and even abolish HO formation. These findings pave the way for pharmacologic inhibitors of hypoxia inducible factor-1α as therapeutic options for heterotopic ossification.

5 February 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
MSMichael Sorkin
Michael Sorkin
AHAmanda K. Huber
Amanda K. Huber
CHCharles Hwang
Charles Hwang
WCWilliam F. Carson
William F. Carson
RMRajasree Menon
Rajasree Menon
BLBenjamin Levi
Benjamin Levi
Heterotopic ossification (HO) is an aberrant regenerative process with ectopic bone induction in response to musculoskeletal trauma, in which mesenchymal stem cells (MSC) differentiate into osteochondrogenic cells instead of myocytes or tenocytes. Despite frequent cases of hospitalized musculoskeletal trauma, the inflammatory responses and cell population dynamics that regulate subsequent wound healing and tissue regeneration are still unclear. Here we examine, using a mouse model of trauma-induced HO, the local microenvironment of the initial post-injury inflammatory response. Single cell transcriptome analyses identify distinct monocyte/macrophage populations at the injury site, with their dynamic changes over time elucidated using trajectory analyses. Mechanistically, transforming growth factor beta-1 (TGFβ1)-producing monocytes/macrophages are associated with HO and aberrant chondrogenic progenitor cell differentiation, while CD47-activating peptides that reduce systemic macrophage TGFβ levels and help ameliorate HO. Our data thus implicate CD47 activation as a therapeutic approach for modulating monocyte/macrophage phenotypes, MSC differentiation and HO formation during wound healing.

1 May 2013 in Bone
Verified
Journal Article
Closed access
JPJonathan R. Peterson
Jonathan R. Peterson
POPaul I. Okagbare
Paul I. Okagbare
SRSara De La Rosa
Sara De La Rosa
KCKatherine E. Cilwa
Katherine E. Cilwa
JPJoseph E. Perosky
Joseph E. Perosky
BLBenjamin Levi
Benjamin Levi

1 January 2016 in Journal of Trauma and Acute Care Surgery
Verified
Journal Article
Closed access
CKCasey T. Kraft
Casey T. Kraft
SAShailesh Agarwal
Shailesh Agarwal
KRKavitha Ranganathan
Kavitha Ranganathan
VWVictor W. Wong
Victor W. Wong
SLShawn Loder
Shawn Loder
BLBenjamin Levi
Benjamin Levi
Extremity trauma, spinal cord injuries, head injuries, and burn injuries place patients at high risk of pathologic extraskeletal bone formation. This heterotopic bone causes severe pain, deformities, and joint contractures. The immune system has been increasingly implicated in this debilitating condition. This review summarizes the various roles immune cells and inflammation play in the formation of ectopic bone and highlights potential areas of future investigation and treatment. Cell types in both the innate and adaptive immune system such as neutrophils, macrophages, mast cells, B cells, and T cells have all been implicated as having a role in ectopic bone formation through various mechanisms. Many of these cell types are promising areas of therapeutic investigation for potential treatment. The immune system has also been known to also influence osteoclastogenesis, which is heavily involved in ectopic bone formation. Chronic inflammation is also known to have an inhibitory role in the formation of ectopic bone, whereas acute inflammation is necessary for ectopic bone formation.

1 October 2020 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
AHAmanda K. Huber
Amanda K. Huber
NPNicole Patel
Nicole Patel
CPChase A. Pagani
Chase A. Pagani
SMSimone Marini
Simone Marini
KPKarthik R. Padmanabhan
Karthik R. Padmanabhan
BLBenjamin Levi
Benjamin Levi
Cells sense the extracellular environment and mechanical stimuli and translate these signals into intracellular responses through mechanotransduction, which alters cell maintenance, proliferation, and differentiation. Here we use a mouse model of trauma-induced heterotopic ossification (HO) to examine how cell-extrinsic forces impact mesenchymal progenitor cell (MPC) fate. After injury, single-cell (sc) RNA sequencing of the injury site reveals an early increase in MPC genes associated with pathways of cell adhesion and ECM-receptor interactions, and MPC trajectories to cartilage and bone. Immunostaining uncovers active mechanotransduction after injury with increased focal adhesion kinase signaling and nuclear translocation of transcriptional coactivator TAZ, inhibition of which mitigates HO. Similarly, joint immobilization decreases mechanotransductive signaling, and completely inhibits HO. Joint immobilization decreases collagen alignment and increases adipogenesis. Further, scRNA sequencing of the HO site after injury with or without immobilization identifies gene signatures in mobile MPCs correlating with osteogenesis, and signatures from immobile MPCs with adipogenesis. scATAC-seq in these same MPCs confirm that in mobile MPCs, chromatin regions around osteogenic genes are open, whereas in immobile MPCs, regions around adipogenic genes are open. Together these data suggest that joint immobilization after injury results in decreased ECM alignment, altered MPC mechanotransduction, and changes in genomic architecture favoring adipogenesis over osteogenesis, resulting in decreased formation of HO.